Claudio Jommi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Topics

Cross Sectional

Decision Making

Top Venues

Global & regional health technology assessment

BMC health services research

Journal of pharmaceutical policy and practice

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Bortolami, Claudio Jommi, Filippo Bresciani, Luca Piccoli, Elisa Sangiorgi, Giovanna Scroccaro
Global & regional health technology assessment 11 (2024)
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study. BMC health services research 24 (1) (2024)
Claudio Jommi, Francesca Patarnello, Cosetta Bianchi, Giuliano Buzzetti
Global & regional health technology assessment 11 (2024)
Alberto Bortolami, Claudio Jommi, Filippo Bresciani, Luca Piccoli, Elisa Sangiorgi, Giovanna Scroccaro
Global & regional health technology assessment 11 (2024)
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study. BMC health services research 24 (1) (2024)
Patrizia Popoli, Giovanni Giuliani, Arturo Cavaliere, Claudio Jommi
Global & regional health technology assessment 11 (2024)
Claudio Jommi, Federico Pantellini, Giovanni Giuliani, Marianna Cavazza
Global & regional health technology assessment 11 (2024)
Claudio Jommi, Federico Pantellini, Giovanni Giuliani, Marianna Cavazza
Global & regional health technology assessment 11 (2024)
Patrizia Popoli, Giovanni Giuliani, Arturo Cavaliere, Claudio Jommi
Global & regional health technology assessment 11 (2024)
Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, Beatrice Casadei, Ilaria Cutini, Barbara Tonietti, Riccardo Saccardi, PierLuigi Zinzani, Claudio Jommi
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study. BMC health services research 24 (1) (2024)
Claudio Jommi, Francesca Patarnello, Cosetta Bianchi, Giuliano Buzzetti
Global & regional health technology assessment 11 (2024)
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espín, Jean Mossman, Gérard de Pouvourville
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? BMC health services research 23 (1) (2023)
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini, Claudio Jommi
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case. Journal of pharmaceutical policy and practice 16 (1) (2023)
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini, Claudio Jommi
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case. Journal of pharmaceutical policy and practice 16 (1) (2023)
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espín, Jean Mossman, Gérard de Pouvourville
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? BMC health services research 23 (1) (2023)
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espín, Jean Mossman, Gérard de Pouvourville
How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy? BMC health services research 23 (1) (2023)
Giorgio Casilli, Dario Lidonnici, Claudio Jommi, Marika De Nigris, Armando A Genazzani
Do France, Germany, and Italy agree on the added therapeutic value of medicines? International journal of technology assessment in health care 39 (1) (2023)
Claudio Jommi, Carlotta Galeone
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency. PharmacoEconomics - open (2023)
Andrea Vingiani, Luca Agnelli, Matteo Duca, Daniele Lorenzini, Silvia Damian, Claudia Proto, Monica Niger, Federico Nichetti, Elena Tamborini, Federica Perrone, Alberta Piccolo, Siranoush Manoukian, Jacopo Azzollini, Marta Brambilla, Elena Colombo, Salvatore Lopez, Claudio Vernieri, Francesca Marra, Elena Conca, Adele Busico, Iolanda Capone, Fabio Bozzi, Marta Angelini, Andrea Devecchi, Rebecca Salvatori, Valentina De Micheli, Anna Baggi, Silvia Pasini, Claudio Jommi, Vito Ladisa, Giovanni Apolone, Filippo De Braud, Giancarlo Pruneri
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care. JCO precision oncology 7 (2023)
Alice Tarantola, Monica Hildegard Otto, Patrizio Armeni, Francesco Costa, Francesco Malandrini, Claudio Jommi
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case. Journal of pharmaceutical policy and practice 16 (1) (2023)
Claudio Jommi, Elisabetta Listorti, Federico Villa, Simone Ghislandi, Armando Genazzani, Agnese Cangini, Francesco Trotta
Variables affecting pricing of orphan drugs: the Italian case. Orphanet journal of rare diseases 16 (1) (2021)
Giancarlo Pruneri, Filippo De Braud, Anna Sapino, Massimo Aglietta, Andrea Vecchione, Raffaele Giusti, Caterina Marchiò, Stefania Scarpino, Anna Baggi, Giuseppe Bonetti, Jean Marie Franzini, Marco Volpe, Claudio Jommi
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? PharmacoEconomics - open 5 (2) (2021)